Table 1:

Patient baseline characteristics for the entire patient sample (n = 367), patients with cardioembolic stroke (n = 226), and patients with cryptogenic stroke (n = 141)

VariableEntire Patient Sample (n = 367)Cardioembolic Stroke (n = 226)Cryptogenic Stroke (n = 141)P Valuea
Age (median) (IQR) (yr)71 (60–81)72 (62–82)69 (59–78).23
Female sex (No.) (%)189/367 (51.5)116/226 (51.3)73/141 (51.8).51
Baseline NIHSS (median) (IQR)16 (12–20)16 (12–20)17 (13–22).09
Comorbidities (No.) (%)
 CAD107 (29.2)68 (30.1)39 (27.7).63
 Previous stroke46 (12.5)32 (14.2)14 (9.9).26
 Previous ICH7 (1.9)3 (1.3)4 (2.8).43
 Previous TIA24 (6.5)14 (6.2)10 (7.1).82
 Diabetes94 (25.6)54 (23.9)40 (28.4).39
 Hypertension267 (72.8)169 (74.8)98 (69.5).28
Smoking (No.) (%)
 Current smoker69/333 (20.7)35/204 (17.2)34/129 (26.4).001
 Former smoker106/333 (31.8)80/204 (39.2)26/129 (24.5).001
ASPECTS (median) (IQR)9 (8–9)9 (8–9)9 (8–9).88
Occlusion site (No.) (%)(n = 330)(n = 210)(n = 120).43
 ICA (intracranial)47 (12.8)28 (12.4)19 (13.5)
 M1235 (64.0)147 (65.0)88 (62.4)
 M265 (17.7)42 (18.6)23 (16.3)
 Other20 (5.5)9 (4.0)11 (7.8)
  • Note:—CAD indicates coronary artery disease; ICH, intracerebral hemorrhage

  • a Derived from the Wilcoxon rank sum test (continuous variables) or Fisher exact test (categoric variables).